Beranda › Multiple Myeloma Smoldering › Massachusetts › Boston
Uji klinis Multiple Myeloma Smoldering di Boston, MA
6 studi untuk Multiple Myeloma Smoldering mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Menerima pesertaFase 3
- Dana Farber / Harvard Cancer Center, Boston
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Menerima pesertaFase 3
- Tufts Medical Center, Boston
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Menerima pesertaFase 2
- Dana Farber Cancer Institute, Boston
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Menerima pesertaFase 2
- Dana-Farber Cancer Institute, Boston
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Menerima pesertaStudi observasional
- Dana-Farber Cancer Institute, Boston
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Menerima pesertaStudi observasional
- Tufts Medical Center, Boston
Uji klinis Multiple Myeloma Smoldering di kota lain
- New York City, NY6 studi
- Atlanta, GA5 studi
- Denver, CO3 studi
- Durham, NC3 studi
- Houston, TX3 studi
- Columbus, OH3 studi
- Salt Lake City, UT3 studi
- Edison, NJ3 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.